ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
benelong
|
449 |
137K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
449
|
137K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
benelong
|
160 |
63K |
18 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
160
|
63K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
benelong
|
226 |
71K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
71K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
benelong
|
226 |
71K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
71K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
benelong
|
102 |
19K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
19K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
6 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
7 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
benelong
|
510 |
148K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
510
|
148K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
benelong
|
510 |
148K |
12 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
510
|
148K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
benelong
|
510 |
148K |
9 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
510
|
148K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
benelong
|
381 |
119K |
11 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
381
|
119K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
20 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
29 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
17K
|
6.5M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
benelong
|
31 |
9.1K |
25 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
31
|
9.1K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
benelong
|
31 |
9.1K |
17 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
31
|
9.1K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
38 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
38
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
57 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
9.2K
|
2.6M
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
26 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
17K
|
6.5M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
23 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
17K
|
6.5M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
benelong
|
574 |
189K |
22 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
574
|
189K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2023 Full Year Financial Results Webcast
|
|
benelong
|
60 |
29K |
7 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
60
|
29K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 Next Steps
|
|
benelong
|
165 |
65K |
15 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
165
|
65K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
benelong
|
160 |
63K |
33 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
160
|
63K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
benelong
|
1.3K |
540K |
29 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
benelong
|
1.3K |
540K |
8 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
benelong
|
3.4K |
1.1M |
34 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
21 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
17K
|
6.5M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
4 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
11 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
benelong
|
3.4K |
1.1M |
8 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
11 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
17K
|
6.5M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
13 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
7 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
benelong
|
55 |
21K |
50 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
55
|
21K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
benelong
|
275 |
110K |
33 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
275
|
110K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
benelong
|
17K |
6.5M |
24 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
17K
|
6.5M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
16 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
18 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
8 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
4 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
benelong
|
9.2K |
2.6M |
9 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
9.2K
|
2.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
benelong
|
13K |
4.9M |
9 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
13K
|
4.9M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Significant sales in fiscal 2024
|
|
benelong
|
68 |
21K |
16 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
68
|
21K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Significant sales in fiscal 2024
|
|
benelong
|
68 |
21K |
23 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
68
|
21K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Significant sales in fiscal 2024
|
|
benelong
|
68 |
21K |
17 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
68
|
21K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Significant sales in fiscal 2024
|
|
benelong
|
68 |
21K |
9 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
68
|
21K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Significant sales in fiscal 2024
|
|
benelong
|
68 |
21K |
39 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
68
|
21K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
benelong
|
1.0K |
380K |
4 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
380K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
benelong
|
1.0K |
380K |
0 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
380K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
benelong
|
1.0K |
380K |
6 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
380K
|
6
|
|